Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference34 articles.
1. Johnson DB, Nebhan CA, Moslehi JJ, Balko JM (2022) Immune-checkpoint inhibitors: long-term implications of toxicity. US, Nat Rev Clin Oncol. Springer, p 0123456789
2. Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science. 359(6382):1350–1355
3. Lee Ventola C. 2017 Cancer immunotherapy, part 3: Challenges and future trends. P T. Medi Media USA Inc. 42:514–21
4. Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S et al (2017) iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol England 18:e143–e152
5. Anwar H, Sachpekidis C, Winkler J, Kopp-Schneider A, Haberkorn U, Hassel JC et al (2018) Absolute number of new lesions on18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. Eur J Nucl Med Mol Imaging. 45:376–83
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献